Tuesday, July 28

Browsing: ESR1Mutated

Support

Camizestrant Extends PFS and PFS2 in ESR1-Mutated Advanced Breast Cancer

By NewsCancerJune 2, 20260

The final progression-free survival 2 (PFS2) results from the phase 3 SERENA-6 trial (NCT04964934), demonstrating that proactively switching to camizestrant…

Diagnosis

TIP137 ADELA: A Double-blind, Placebo-Controlled, Randomized Phase 3 Trial of Elacestrant + Everolimus Versus Elacestrant + Placebo in ER+/HER2- Advanced Breast Cancer (aBC) Patients With ESR1-Mutated Tumors Progressing on Endocrine Therapy (ET) + CDK4/6i

By NewsCancerMay 2, 20260

BackgroundEndocrine therapy (ET) plus CDK4/6 inhibitor (CDK4/6i) is the standard-of-care (SOC) in first-line estrogen receptor–positive (ER+/HER2-negative (HER2–) advanced breast cancer;…

Support

FDA Approves Vepdegestrant in ER+, HER2–, ESR1-Mutated Breast Cancer

By NewsCancerMay 1, 20260

The FDA has approved vepdegestrant (Veppanu) for patients with estrogen receptor (ER)–positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer, which…

Survivors

FDA Accepts NDA for Giredestrant/Everolimus in ESR1-Mutated Breast Cancer

By NewsCancerFebruary 20, 20260

The FDA had accepted a new drug application for giredestrant plus everolimus (Afinitor) for the treatment of patients with estrogen…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

What's Hot

Fixed-dose inotuzumab ozogamicin (INO) combined with Vincristine and Prednisone (VP) regimen as induction therapy for newly diagnosed B-cell acute lymphocytic leukemia (B-ALL): a multi-center, open-label, single-arm, prospective clinical study

Steel Particulate Matter Prompts Cyclophosphamide for Injection Recall

Amy Dowden says Strictly Come Dancing partner Carlos Gu convinced her not to quit dancing

Browsing: ESR1Mutated

Camizestrant Extends PFS and PFS2 in ESR1-Mutated Advanced Breast Cancer

TIP137 ADELA: A Double-blind, Placebo-Controlled, Randomized Phase 3 Trial of Elacestrant + Everolimus Versus Elacestrant + Placebo in ER+/HER2- Advanced Breast Cancer (aBC) Patients With ESR1-Mutated Tumors Progressing on Endocrine Therapy (ET) + CDK4/6i

FDA Approves Vepdegestrant in ER+, HER2–, ESR1-Mutated Breast Cancer

FDA Accepts NDA for Giredestrant/Everolimus in ESR1-Mutated Breast Cancer

Fixed-dose inotuzumab ozogamicin (INO) combined with Vincristine and Prednisone (VP) regimen as induction therapy for newly diagnosed B-cell acute lymphocytic leukemia (B-ALL): a multi-center, open-label, single-arm, prospective clinical study

Steel Particulate Matter Prompts Cyclophosphamide for Injection Recall

Amy Dowden says Strictly Come Dancing partner Carlos Gu convinced her not to quit dancing

Navigating Insurance Hurdles for Oral AML Therapy Access

Fixed-dose inotuzumab ozogamicin (INO) combined with Vincristine and Prednisone (VP) regimen as induction therapy for newly diagnosed B-cell acute lymphocytic leukemia (B-ALL): a multi-center, open-label, single-arm, prospective clinical study

Steel Particulate Matter Prompts Cyclophosphamide for Injection Recall

Amy Dowden says Strictly Come Dancing partner Carlos Gu convinced her not to quit dancing

Navigating Insurance Hurdles for Oral AML Therapy Access

Latest Post

Fixed-dose inotuzumab ozogamicin (INO) combined with Vincristine and Prednisone (VP) regimen as induction therapy for newly diagnosed B-cell acute lymphocytic leukemia (B-ALL): a multi-center, open-label, single-arm, prospective clinical study

Steel Particulate Matter Prompts Cyclophosphamide for Injection Recall

Amy Dowden says Strictly Come Dancing partner Carlos Gu convinced her not to quit dancing

Subscribe to Updates

What's Hot

Browsing: ESR1Mutated